Healthcare | February 15, 2022
India’s tech-enabled vaccination drive applauded at India-Africa Health Summit
It will open new frontier for south-to-south collaboration and innovation transfer
It will open new frontier for south-to-south collaboration and innovation transfer
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
Dr. Reddy’s to promote and distribute select Novartis products including the Voveran range, the Calcium range and Methergine in India
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
In the first phase of the Grangemouth site expansion, two new ADC manufacturing suites, operational by Q3 2023, will be added to the existing three
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
The target demographic will be those between the ages of 30 and 65 years
It has signed an MoU with Plan India to expand its reach to Karnataka
The new centre will comprise a team of 50 highly experienced specialists
Subscribe To Our Newsletter & Stay Updated
